Literature DB >> 11223001

Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats.

B Greenwood-Van Meerveld1, M Gibson, W Gunter, J Shepard, R Foreman, D Myers.   

Abstract

Episodes of anxiety are often associated with the onset or exacerbation of visceral pain in patients with irritable bowel syndrome (IBS). The central amygdaloid nucleus (CeA) is a key limbic structure involved in the expression of anxiety as well as a major site for regulating autonomic and visceral responses to stress. Previous experiments have shown that glucocorticoids can act directly at the CeA to increase the level of anxiety in rats. Therefore, the goal of this study was to examine the effect of stereotaxic delivery of corticosterone into the CeA on the development of visceral hypersensitivity by measuring visceromotor response to colorectal distention in rats. Stereotaxic delivery of corticosterone to the CeA increases indices of anxiety and produces a hypersensitive colon as demonstrated by an exaggerated visceromotor response to colorectal distention in the F344 rat strain. Our findings suggest that modulation of anxiety by manipulating amygdala function with corticosterone induced colonic hypersensitivity via descending neuronal pathways from the CeA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223001     DOI: 10.1016/s0006-8993(00)03305-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  48 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

2.  Footshock stress differentially affects responses of two subpopulations of spinal dorsal horn neurons to urinary bladder distension in rats.

Authors:  Meredith T Robbins; Jennifer Deberry; Alan Randich; Timothy J Ness
Journal:  Brain Res       Date:  2011-03-02       Impact factor: 3.252

3.  Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala.

Authors:  J J Maire; L N Close; M M Heinricher; N R Selden
Journal:  Eur J Pain       Date:  2015-04-05       Impact factor: 3.931

Review 4.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

5.  Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat.

Authors:  A C Johnson; L Tran; J Schulkin; B Greenwood-Van Meerveld
Journal:  Neurogastroenterol Motil       Date:  2012-02-26       Impact factor: 3.598

6.  Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.

Authors:  Lee Tran; Jay Schulkin; Beverley Greenwood-Van Meerveld
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

7.  Lesions of the central amygdala and ventromedial medulla reduce bladder hypersensitivity produced by acute but not chronic foot shock.

Authors:  Alan Randich; Cary DeWitte; Jennifer J DeBerry; Meredith T Robbins; Timothy J Ness
Journal:  Brain Res       Date:  2017-09-01       Impact factor: 3.252

Review 8.  Studying the brain-gut axis with pharmacological imaging.

Authors:  Kirsten Tillisch; Zhuo Wang; Lisa Kilpatrick; Daniel P Holschneider; Emeran A Mayer
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Behavioral effects of chronically elevated corticosterone in subregions of the medial prefrontal cortex.

Authors:  Joshua D Croteau; Jay Schulkin; Jack D Shepard
Journal:  Behav Brain Res       Date:  2016-08-28       Impact factor: 3.332

10.  Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study.

Authors:  Anthony C Johnson; Brent Myers; Jelena Lazovic; Rheal Towner; Beverley Greenwood-Van Meerveld
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.